scholarly journals Osteoporosis in Human Immunodeficiency Virus Patients – An Emerging Clinical Concern

2010 ◽  
Vol 10 (1) ◽  
pp. 79 ◽  
Author(s):  
Filippo Maffezzoni ◽  
Teresa Porcelli ◽  
Ioannis Karamouzis ◽  
Eugenia Quiros-Roldan ◽  
Francesco Castelli ◽  
...  

The advent of highly active anti-retroviral therapy (HAART) has significantly improved the survival of human immunodeficiency virus (HIV)-infected patients transforming the HIV infection from a fatal illness into a manageable chronic disease. As the number of older HIV-infected individuals increases, several ageing-related co-morbidities including osteopenia/osteoporosis and fractures have emerged. Patients exposed to HIV infection and its treatment may develop fragility fractures with potential significant impact on quality of life and survival. However, the awareness of HIV-related skeletal fragility is still relatively low and most HIV-infected patients are not investigated for osteoporosis and treated with anti-osteoporotic drugs in daily clinical practice. This article reviews the literature data on osteoporosis and osteopenia in HIV infection, focusing on the pathophysiological, clinical and therapeutic aspects of fragility fractures.

2014 ◽  
Vol 10 (01) ◽  
pp. 84 ◽  
Author(s):  
Filippo Maffezzoni ◽  
Teresa Porcelli ◽  
Ioannis Karamouzis ◽  
Eugenia Quiros-Roldan ◽  
Francesco Castelli ◽  
...  

The advent of highly active anti-retroviral therapy (HAART) has significantly improved the survival of human immunodeficiency virus (HIV)- infected patients transforming the HIV infection from a fatal illness into a manageable chronic disease. As the number of older HIV-infected individuals increases, several aging-related co-morbidities including osteopenia/osteoporosis and fractures have emerged. Patients exposed to HIV infection and its treatment may develop fragility fractures with potential significant impact on quality of life and survival. However, the awareness of HIV-related skeletal fragility is still relatively low and most HIV-infected patients are not investigated for osteoporosis and treated with anti-osteoporotic drugs in daily clinical practice. This article reviews the literature data on osteoporosis and osteopenia in HIV infection, focusing on the pathophysiological, clinical, and therapeutic aspects of fragility fractures.


1997 ◽  
Vol 59 (2) ◽  
pp. 187-192 ◽  
Author(s):  
William C. Holmes ◽  
Barbara Bix ◽  
Mary Meritz ◽  
John Turner ◽  
Carol Hutelmyer

ESC CardioMed ◽  
2018 ◽  
pp. 1190-1193
Author(s):  
Ntobeko A. B. Ntusi

Cardiovascular disease is common in persons living with the human immunodeficiency virus (HIV). HIV-associated cardiovascular disease may involve every segment of the cardiovascular tree. Recent reports suggest that the incidence of HIV-associated heart failure is on the increase. The phenotype of HIV-associated heart failure is evolving, with predominance of diastolic dysfunction, rather than systolic dysfunction and myocarditis. Widespread availability and utility of antiretroviral therapy has significantly altered the natural history of HIV infection, and improved survival and quality of life of persons with HIV infection. The epidemiology, pathophysiology, and management of HIV-associated cardiomyopathy and myocarditis are reviewed in this chapter.


2015 ◽  
Vol 31 (9) ◽  
pp. 485-492 ◽  
Author(s):  
Ming-Chu Feng ◽  
Jui-Ying Feng ◽  
Chien-Tai Yu ◽  
Li-Hua Chen ◽  
Pei-Hsuan Yang ◽  
...  

2019 ◽  
Vol 9 (4) ◽  
pp. 249-256 ◽  
Author(s):  
Wan Nazirah Wan Yusuf ◽  
Wan Mohd Zahiruddin Wan Mohammad ◽  
Siew Hua Gan ◽  
Mahiran Mustafa ◽  
Che Badariah Abd Aziz ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document